Evidence map›Paper›PMID 37066216›Full record

ArticlebioRxiv : the preprint server for biology2023

Distinct roles of

Svitlana V Bach, Allison J Bauman, Darya Hosein, Jennifer J Tuscher, Lara Ianov, Kelsey M Greathouse, Benjamin W Henderson, Jeremy H Herskowitz, Keri Martinowich, Jeremy J Day

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Svitlana V BachThe Lieber Institute for Brain Development, Baltimore, MD 21205, USA.
Allison J BaumanDepartment of Neurobiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Darya HoseinDepartment of Neurobiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Jennifer J TuscherDepartment of Neurobiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Lara IanovDepartment of Neurobiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Kelsey M GreathouseDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Benjamin W HendersonDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Jeremy H HerskowitzDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Keri MartinowichThe Lieber Institute for Brain Development, Baltimore, MD 21205, USA.
Jeremy J DayDepartment of Neurobiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
University of Alabama at Birmingham · USCivitan International · USJohns Hopkins University · USLieber Institute for Brain Development · US

Funding

Identifying therapeutic targets that confer synaptic resilience to Alzheimer's diseaseR01AG061800 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Christopher A. Gaiteri, Jeremy H. Herskowitz · 2018 to 2026
$6.9M
Regulation of neural activity in fear circuits by promoter IV derived BDNFR01MH105592 · NIMH · LIEBER INSTITUTE, INC. · PI MARTINOWICH, KERI · 2015 to 2024
$5.6M
UAB Research Training Program in Neurobiology of Cognition and Cognitive DisordersT32NS061788 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Farah Dominique Lubin · 2008 to 2026
$4.5M
Epigenetic Control of Brain Reward SystemsDP1DA039650 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DAY, JEREMY J · 2015 to 2019
$2.3M
Enhancer RNA Regulation of Experience-dependent Neuroepigenetic ProcessesR01MH114990 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DAY, JEREMY J · 2018 to 2022
$2.3M
Targeting Rho Kinases for Alzheimer's disease TherapeuticsR01AG054719 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HERSKOWITZ, JEREMY H. · 2017 to 2021
$1.9M
Synaptic Resilience to Tau in Alzheimer's DiseaseR21AG085379 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HERSKOWITZ, JEREMY H. · 2024 to 2025
$401k
CRISPR/dCas9-Targeted Manipulation of Bdnf Transcription in Synaptic Plasticity and Contextual LearningF32MH112304 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BACH, SVITLANA · 2016 to 2018
$174k
NIA NIH HHS R01 AG054719NIA NIH HHS R01 AG061800NIA NIH HHS R21 AG085379NIDA NIH HHS DP1 DA039650NIMH NIH HHS F32 MH112304NIMH NIH HHS R01 MH105592NIMH NIH HHS R01 MH114990NINDS NIH HHS T32 NS061788
6 · The paper itself

Abstract

Brain-derived neurotrophic factor (

Identifiers

PMID37066216
PMCPMC10104043
OpenAlexW4362640627

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.